News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Agenix Limited CEO Donald Home Resigns
December 16, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
16/12/2005 15:01:36 Donald Home has resigned as CEO and managing director of Brisbane-based Agenix (ASX:AGX, NASDAQ:OTC:AGXLY) after four and a half years with the company. More...
Twitter
LinkedIn
Facebook
Email
Print
People
Australia
MORE ON THIS TOPIC
Collaboration
Crescent, Kelun-Biotech Swap Therapies in ADC-Bispecific Deal Worth Up To $1.25B
December 4, 2025
·
2 min read
·
Tristan Manalac
Policy
New UK/EU Rules and AI Adoption Define CRO Priorities for 2026
December 3, 2025
·
4 min read
·
Jennifer Smith-Parker
FDA
Pazdur To Retire Weeks After Taking On Coveted FDA Role
December 2, 2025
·
3 min read
·
Heather McKenzie
Manufacturing
Biotechs Secure Alternative Fill/Finish Capacity Amid Scrutiny of Novo Site
December 2, 2025
·
6 min read
·
Nick Paul Taylor
